Opioids in chronic noncancer pain: More faces from the crowd

Pain Research and Management

Volumn 17, Issue 4, 2012, Pages 263-275

  Watson, C Peter N ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chronic noncancer pain; Long term safety and efficacy; Opioids

Indexed keywords

ACETYLSALICYLIC ACID PLUS CODEINE PHOSPHATE; AMITRIPTYLINE; ANILERIDINE; CARBAMAZEPINE; DOXEPIN; FENTANYL; GABAPENTIN; MORPHINE; NORTRIPTYLINE; OPIATE; OXYCODONE; OXYCODONE PLUS PARACETAMOL;

ACHILLES REFLEX; ADULT; AGED; ALLODYNIA; ANALGESIA; ARACHNOIDITIS; ARTHRITIS; BEDTIME DOSAGE; BRACHIAL PLEXUS NEUROPATHY; CAUSALGIA; CHRONIC DAILY HEADACHE; CHRONIC NONCANCER PAIN; CHRONIC PAIN; CLINICAL ARTICLE; CONSTIPATION; CROHN DISEASE; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE SEVERITY; DROWSINESS; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG SENSITIVITY; DRUG TOLERABILITY; DRUG USE; FEMALE; FUNCTIONAL STATUS; GUNSHOT INJURY; HUMAN; IMMUNE STATUS; LEG PAIN; LETHARGY; LIMB PAIN; LONG TERM CARE; LOW BACK PAIN; LOW DRUG DOSE; MALE; NAUSEA AND VOMITING; NEUROPATHY; OSTEOARTHRITIS; OSTEOMYELITIS; PAIN; PHANTOM PAIN; POSTHERPETIC NEURALGIA; QUALITY OF LIFE; REVIEW; SEXUAL FUNCTION; SIDE EFFECT; TRIGEMINUS NEURALGIA; WEIGHT GAIN; XEROSTOMIA;

EID: 84866751945     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/495781     Document Type: Review

References (55)

1. Ballantyne J. Opioids around the clock? Pain 2011;152:1221-2.
2. Dhalla I. The Medical Post, October 4, 2011, page 75.
3. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic non-cancer pain. J Pain 2009;10:113-30.
4. Moulin DE, Clark AJ, Speechley M, Morley-Forster PK. Chronic pain in Canada - prevalence, treatment, impact and the role of opioid analgesia. Pain Res Manage 2002;79:179-84.
5. Sjogren P. Epidemiology of pain and critical issues in opioid use. Pain 2011;152:1219-20.
6. Eriksen J, Jensen MK, Sjogren P, Ekholm O, Rasmussen NK. Epidemiology of chronic non-malignant pain in Denmark. Pain 2003;106:221-8.
7. Sjogren P, Ekholm O, Peuckmann V, Groenbaek M. Epidemiology of chronic pain in Denmark: An update. Eur J Pain 2009;13:287-92.
8. Toblin RL, Mack KA, Perveen G, Paulozzi LJ. A population based survey of chronic pain and its treatment with prescription drugs. Pain 2011;1152:1249-55.
9. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: A World Health Organization study in primary care. JAMA 1998;280:147-51.
10. Joransen DE. Improving availability of opioid pain medications: Testing the principle of balance in Latin America. J Pall Med 2004;7:105-14.
11. Claussen TG, Eriksen J, Borgbjerg FM. Legal opioid consumption in Denmark in 1981-1993. Eur J Clin Pharmacol 1995;48:321-5.
12. Dhalla IA, Mamdani MM, Silviotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009;181:891-6.
13. Okie S. A flood of opioids, a rising tide of deaths. N Eng J Med 2010;363;1981-5.
14. Gomes T, Juurlink DN, Dhalla IA, Mailis-Gagnon A, Paterson JM, Mamdani MM. Trends in opioid use and dosing among socioeconomically disadvantaged patients. Arch Int Med 2011;171:686-91.
15. Watson CPN. External validity of pharmaceutical trials in neuropathic pain. In: Rothwell PM, ed. Treating Individuals: From Randomized Trials to Personalized Medicine. Philadelphia: Elsevier, 2007:121-30.
16. Watson CPN, Gilron I, Sawynok J. A qualitative, systematic review of head-to-head randomized, controlled trials of oral analgesics in neuropathic pain. J Pain Res Manage 2010;15:147-57.
17. Watson CPN, Gilron I, Sawynok J, Lynch ME. Nontricyclic antidepressants and pain: Are serotonin norepinephrine re-uptake inhibitors (SNRIs) any better? Pain 2011;152:2206-10.
18. Watson CPN, Babul N. Oxycodone relieves neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 1998;50:1837-41.
19. Harati Y Gooch C, Swensen M, et al. Double blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50:1842-6.
20. Sindrup SH, Andersen G, Madsen C, et al. Tramadol relieves pain and allodynia in polyneuropathy: A randomized, double-blind, controlled trial. Pain 1999;83:85-90.
21. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain N Engl J Med 2003;349:1223-32.
22. Raja SJ, Haythornethwaite JA, Papagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: A placebo-controlled study. Pain 2002;94:215-24.
23. Watson CPN, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain 2003;105;71-7.
24. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial. Neurology 2003;60:927-34.
25. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in postherpetic neuralgia: A randomized, double-blind, placebo-controlled trial. Pain 2003;104:323-31.
26. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin or their combination for neuropathic pain. N Engl J Med 2005;352:1324-34.
27. Khoromi S, Cui L, Nackers L, Max MB. Morphine versus nortriptyline and their combination in chronic lumbar root pain. Pain 2007;130:66-75.
28. Jaffe J. Opiates: Clinical aspects. In: Lowinson JH, Ruiz P, Millman RG, eds. Substance Abuse. A Comprehensive Textbook. Baltimore: Williams and Wilkins, 1992:186-94.
29. Sees KL, Clark KW. Opioid use in the treatment of chronic pain: Assessment of addiction. J Pain Symptom Manage 1993;8:257-64.
30. Savage SR. Long-term opioid therapy: Assessment of consequences and risks. J Pain Symptom Manage 1996;11:274-86.
31. Sacerdote P, Manfredi B, Manttegazza P, Panerai AE. Antinociceptive and immunosuppressive effects of opiate drugs: A structure-related activity study. Br J Pharmacol 1997;121:834-40.
32. Sjogren P, Olsen AK, Thomsen AB. Impaired neuropsychological performance in chronic non-malignant pain patients receiving long-term oral therapy. J Pain Symptom Manage 2000;19:100-8.
33. Mao J. Opioid-induced abnormal pain sensitivity: Implications in clinical opioid therapy. Pain 2002;100:213-7.
34. Rajogopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Brera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to morphine. Cancer 2004;100:851-8.
35. Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression. A review. Am J Ther 2004;11:354-65.
36. Becker N, Thomsen AB, Olsen AK, Sjogren P, Bech P, Eriksen J. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain 2000;73:393-400.
37. Jensen MK, Thomsen AB, Hojsted J. 10 year follow-up of chronic non-malignant pain patients: Opioid use, health related quality of life and health care utilization. Eur J Pain 2006;10:423-33.
38. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues in chronic non-cancer pain: An epidemiological study. Pain 2006;125:172-9.
39. Taub A. Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. In: Kitahata LM, Collins D, eds. Narcotic Analgesics in Anesthesiology. Baltimore: Williams and Wilkins. 1982:199-208.
40. Portenoy RK, Foley RM. Chronic use of opioid analgesics in non-malignant pain. Report of 38 cases. Pain 1986;25:171-86.
41. Tennant FS, Robinson D, Sagherian A, Seecof R. Chronic opioid treatment of intractable non-malignant pain. NIDA Res Monogr 1988;81:174-80.
42. Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with nonmalignant pain. J Pain Symptom Manage 1992;7:69-77.
43. Watson CPN, Watt-Watson J, Chipman ML. Chronic non-cancer pain and the long term utility of opioids. Pain Res Manage 2004;9:19-24.
44. Watson CPN, Watt-Watson JH, Chipman MA. The long-term efficacy and safety of opioids: A survey of 84 selected patients with intractable chronic non-cancer pain. Pain Res Manage 2010;15:213-8.
45. Watson CPN. Opioids in chronic non-cancer pain: Some blind men and an elephant? Scand J Pain 2012;3:5-13.
46. Furlan AD, Reardon R, Weppler C. Opioids for chronic non-cancer pain: A new Canadian practice guideline. CMAJ 2010;182:923-30.
47. Daut IE, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983;17:197-210.
48. Tait RC, Chibnall JT, Krause S. The The Pain Disability Index: Psychometric properties. Pain 1990;40:171-82.
49. Chibnall JT, Tait RC. The Pain Disability Index: Factor structure and normative data. Arch Phys Med Rehabil 1994;75:1082-6.
50. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983:67;361-70.
51. Ware JE, Kosinski M, Keller SD. A 12-item Short-Form Health survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
52. Kieburtz K, Simpson D, Yiannoutsios C, et al; and the AIDs Clinical Trial Group 242 Protocol Team. A randomized trial of amitriptyline and mexiletine in painful neuropathy in HIV infection. Neurology 1998;51:1682-8.
53. Mitchell SW. Injuries of Nerves and Their Consequences. Philadelphia: JB Lippincott & Co, 1872:270.
54. Butler SF, Fernandez K, Benoit C, et al. Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R). J Pain 2005;9;345-52.
55. Webster LR, Webster RM. Predicting aberrant behaviour in opioid-treated patients: Preliminary validation of the opioid risk tool. Pain Med 2005;6:432-42.